Paediatric meningiomas: a multi-centre case series of 27 patients

Luke Rhys Mattey1, Zoë James2, Taha Lilo3

  • 1Cardiff University School of Medicine, Cardiff, Wales, UK. lukermattey@gmail.com.

Insights

Paediatric meningiomas show higher recurrence rates for grade 1 tumors than in adults. The World Health Organization (WHO) grading system may not fully reflect recurrence risk in children, necessitating further research.

Area of Science:

  • Pediatric neurosurgery
  • Neuro-oncology
  • Tumor biology

Background:

  • Meningiomas are rare in children, with limited data on their specific characteristics and outcomes.
  • Understanding paediatric meningiomas is crucial for developing targeted treatment strategies.

Purpose of the Study:

  • To analyze the aetiology, risk factors, and outcomes of paediatric meningiomas.
  • To compare paediatric meningioma data with existing literature on adult cases.

Main Methods:

  • Retrospective review of 27 surgically treated paediatric meningiomas across three UK centers over 15 years.
  • Data collected included patient demographics, tumor characteristics (location, grade, histology), treatment details, complications, and outcomes.
  • Associated conditions, particularly neurofibromatosis type 2 (NF2), were also recorded.

Main Results:

  • 27 patients underwent 39 procedures; 75% were WHO grade 1, 21% grade 2, and 4% grade 3.
  • Eight patients (30%) had confirmed NF2; 12 (44%) were sporadic.
  • Recurrence rates were 25% for WHO grade 1 and 50% for WHO grade 2 meningiomas.

Conclusions:

  • Paediatric meningiomas, particularly grade 1, exhibit higher recurrence rates than adult counterparts.
  • The current WHO grading system may not accurately predict recurrence risk in pediatric cases.
  • Further molecular profiling and larger cohort studies are essential due to the rarity of these tumors.
Abstract